95 related articles for article (PubMed ID: 2580626)
1. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Fryling CM; Iwata KK; Johnson PA; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2695-9. PubMed ID: 2580626
[TBL] [Abstract][Full Text] [Related]
2. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Iwata KK; Fryling CM; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
[TBL] [Abstract][Full Text] [Related]
3. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.
Levine AE; McRae LJ; Hamilton DA; Brattain DE; Yeoman LC; Brattain MG
Cancer Res; 1985 May; 45(5):2248-54. PubMed ID: 3857117
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a novel transforming growth factor.
Halper J; Moses HL
Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
[TBL] [Abstract][Full Text] [Related]
5. Latent transformed growth-inhibiting factor in human malignant effusions.
Podolsky DK; Pleskow DK; Jafari H
Cancer Res; 1988 Jan; 48(2):418-24. PubMed ID: 3257164
[TBL] [Abstract][Full Text] [Related]
6. Epithelial tissue-derived growth factor-like polypeptides.
Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1972-9. PubMed ID: 6572559
[TBL] [Abstract][Full Text] [Related]
7. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.
Siegfried JM
Cancer Res; 1987 Jun; 47(11):2903-10. PubMed ID: 3032416
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
9. Characterization and partial purification of human epithelial transforming growth factor.
Dunnington DJ; Scott RG; Anzano MA; Greig R
J Cell Biochem; 1990 Dec; 44(4):229-39. PubMed ID: 2095367
[TBL] [Abstract][Full Text] [Related]
10. A small molecular weight growth inhibitory factor in tissue culture supernatants.
Djerassi I
J Med; 1983; 14(5-6):415-32. PubMed ID: 6583300
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
Brown TJ; Lioubin MN; Marquardt H
J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
[TBL] [Abstract][Full Text] [Related]
12. Autocrine tumor cell growth-inhibiting activities from human malignant melanoma.
Bogdahn U; Apfel R; Hahn M; Gerlach M; Behl C; Hoppe J; Martin R
Cancer Res; 1989 Oct; 49(19):5358-63. PubMed ID: 2766302
[TBL] [Abstract][Full Text] [Related]
13. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
14. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
[TBL] [Abstract][Full Text] [Related]
16. Purification of melanoma growth stimulatory activity.
Richmond A; Thomas HG
J Cell Physiol; 1986 Dec; 129(3):375-84. PubMed ID: 3465735
[TBL] [Abstract][Full Text] [Related]
17. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor production by chemically transformed cells.
Moses HL; Branum EL; Proper JA; Robinson RA
Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
[TBL] [Abstract][Full Text] [Related]
19. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
20. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.
Manishen WJ; Sivananthan K; Orr FW
Am J Pathol; 1986 Apr; 123(1):39-45. PubMed ID: 3457536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]